We ensure high quality execution of global trials

Scientific Investigator Networks are a vital element in both academic and clinical research settings. Among peers in the scientific community, investigators communicate and collaborate directly, contributing to the advance of the study imperatives. For this reason, within the clinical research setting, advantages are gained when coordinated research networks are maintained and managed.

Julius Clinical has set up and invested in the following networks:

  • PCRN (Primary Care Research Network)
  • ReSViNET (RSV Network)
  • SurgeryNET



The Primary Care Research Network (PCRN) focuses on performing high-quality research by utilising a group of motivated and qualified general practitioners, pharmacists, practice assistants and practice nurses with an interest in clinical scientific research.

The Julius Clinical research network works closely with the Julius Center for Health Sciences and Primary Care at the UMC Utrecht.

In the Netherlands, the Julius Clinical Primary Care Research Network (PCRN) comprises nearly 1,000 medical professionals who are involved in clinical (drug) research, co-ordinated in the primary care setting by Julius Clinical.

Please visit the PCRN website to learn more about this network.


ReSViNET is a global network of experts in the field of Respiratory Syncytial Virus (RSV) infections. RSV is a cyclical illness, and the ReSViNET global network ensures that trials can be conducted throughout the year, following the outbreak of the disease across continents and hemispheres. Because of this, the ReSViNET Board Members are located around the world, making it a truly international network.

The objectives of the network are to:

  • Combine the knowledge and capacity required to enhance development of novel RSV therapeutics.  
  • Advocate and create awareness for the RSV disease.
  • To stimulate and perform cutting- edge research, with a focus on randomized clinical trials.
  • To advocate appropriate allocation of resources for RSV related research and introduction of prevention and treatment strategies for better care for patients with RSV infection.
  • To bring together information related to RSV infection to all stakeholders.
  • To act as a focal point for effective partnerships with stakeholders with the ultimate aim of reducing global child morbidity and mortality.

The Mission of the Network is to support performance of high quality research, to improve knowledge of RSV epidemiology, and to develop safe and effective therapeutic and preventive interventions.

The Vision of the Network is to connect global expertise and leadership in order to decrease the global burden of RSV infection.

Please visit the ReSViNET website if you would like to learn more about ReSViNET.


SurgeryNET is a global network of clinicians and  more than 300 partner clinics and academic hospitals. Through the network, more than 100 studies have been concluded, with more than 12,000 patients worldwide.

The objectives of SurgeryNET are to:

  • Maximise capacity in order to provide an efficient resource for conducting clinical studies;
  • Foster close relationships between the surgical community, academic societies and universities; and
  • Investigate and improve the performance of surgical procedures, devices and substances.

The network has experts in the fields of oral and maxillofacial surgery, plastic surgery, ear, nose and throat, head and neck surgery, ophthalmology and neurosurgery.